In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Procyon receives Canadian tumour patent
Procyon gains additional patent protection for cancer screening test
Procyon and Biovation sign development agreement
Procyon enters into cancer technology option agreement
Procyon extends licence option agreement with Chiron
Procyon and Chiron not to extend license option
Procyon BioPharma Signs Agreements with American Manufacturers
Procyon enters into a license option agreement
Procyon licenses marketing rights for Fibrostat to Biovail
Umicore, Solvay join forces to develop and supply core technology for fuel cell industry